BioNeutra Global Corporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was CAD 10.372 million compared to CAD 8.390 million a year ago. Net loss was CAD 913,432 compared to CAD 839,122 a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.02 a year ago. For the nine months, sales was CAD 28.025 million compared to CAD 30.436 million a year ago. Net loss was CAD 6.704 million compared to net income of CAD 1.390 million a year ago. Basic loss per share was CAD 0.14 compared to basic earnings per share of CAD 0.03 a year ago.